Market Dynamics
September 9, 2011 source: originally published in the San Francisco Business Times Gene Security Network’s race to develop safer, more accurate prenatal test is all business for Matt Rabinowitz — and it’s personal. A relative of Rabinowitz, Gene Security Network’s CEO, took a blood test for the likelihood of Down’s syndrome in her unborn baby and […]
Read MoreDecember 12, 2011 source: originally published at Pessimism about the clean tech space has been on the rise recently, thanks in part to a pair of high profile failures of government-backed companies. Congress and the media have pounced on the carrion like starving scavengers. In the frenzy of sensationalism, it is hard for the public […]
Read MoreSeptember 23, 2011 source: Forbes What the Solyndra Bankruptcy Means for Cleantech Investors by Jennifer Kho. Forbes Contributor As executives of defunct solar-panel manufacturer Solyndra keep mum in Washington, Silicon Valley and Wall Street are discussing what the bankruptcy – and the federal investigation – could mean for investors. “It has an impact; it’s such a […]
Read More
September 17, 2011 source: AOL Energy Although venture capitalists have taken a battering in the renewables sector, as seen in the sorry Solyndra saga, investors continue to see value in smart grid investments, biofuels and electric vehicles. But the stakes are usually high, the capital costs expensive and the path to profit unclear in […]
Read MoreSeptember 15, 2011 source: Xconomy For a while, I was optimistic that 2011 would be a good year for venture capital-backed IPOs, and it wasn’t just wishful thinking. There were 72 VC-backed IPOs last year—six times as many as in 2009. The year ended with a bang and 2011 got off to a good start. […]
Read MoreEntrepreneurs and venture-backed companies seeking financing in the near term, take notice. The hot market for companies is going to cool off in 3 to 6 months. Hurry up and get your round closed before it gets harder and terms get tougher. In my 20 years of participating in the venture market both as a […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.